HIV prevention messages for teens and young adults
Biomedical HIV prevention messaging among adolescents
Researchers are creating short, youth-friendly video messages to help teens and young adults learn about biomedical HIV prevention options like oral and injectable PrEP.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11402007 on NIH RePORTER |
What this research studies
If you are 13–21, you could join an online survey about what you know, believe, and plan to do about biomedical HIV prevention. The team will use those survey results to design eight brief, youth-centered video vignettes about PrEP and other prevention options. Youth will be shown the videos to see whether the messages are clear, relatable, and likely to change knowledge or intentions. Most participation appears to be online and aimed at understanding and improving prevention messaging for adolescents and young adults across the U.S.
Who could benefit from this research
Good fit: Ideal candidates are adolescents and young adults aged 13–21 across the United States, especially those interested in learning about HIV prevention.
Not a fit: People older than 21, those not comfortable with online participation, or those who already have comprehensive knowledge of PrEP may not gain new information from this work.
Why it matters
Potential benefit: Clearer, youth-focused messages could increase awareness and understanding of PrEP and other prevention options, which may lead to better prevention choices among adolescents.
How similar studies have performed: Prior public-health messaging around biomedical prevention has been inconsistent, and specifically designed youth video messaging is relatively new and promising but not yet widely proven.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Macapagal, Kathryn Rose — Northwestern University
- Study coordinator: Macapagal, Kathryn Rose
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.